Table 6 |
||||||
|
Comparison of sensitivity, specificity, PPV and NPV of combined markers expression in Benign vs. Malignant Thyroid Lesions |
||||||
|
MARKER |
Negative |
Positive |
Total |
|||
|
|
||||||
|
GAL-3 + HBME-1 |
Benign |
134 |
62 |
196 |
Sensitivity |
0.861 |
|
Malignant |
15 |
93 |
108 |
Specificity |
0.684 |
|
|
Total |
149 |
155 |
304 |
PPV |
0.600 |
|
|
NPV |
0.899 |
|||||
|
GAL-3 + CK-19 |
Benign |
138 |
58 |
196 |
Sensitivity |
0.852 |
|
Malignant |
16 |
92 |
108 |
Specificity |
0.704 |
|
|
Total |
154 |
150 |
304 |
PPV |
0.613 |
|
|
NPV |
0.896 |
|||||
|
HBME-1 + CK-19 |
Benign |
130 |
66 |
196 |
Sensitivity |
0.861 |
|
Malignant |
15 |
93 |
108 |
Specificity |
0.663 |
|
|
Total |
145 |
159 |
304 |
PPV |
0.585 |
|
|
NPV |
0.897 |
|||||
|
GAL-3+HBME+CK-19 |
Benign |
201 |
93 |
294 |
Sensitivity |
0.858 |
|
Malignant |
23 |
139 |
162 |
Specificity |
0.684 |
|
|
Total |
224 |
232 |
456 |
PPV |
0.599 |
|
|
NPV |
0.897 |
|||||
|
|
||||||
|
Gal-3, galectin-3; Ret, Ret oncoprotein; CK19, cytokeratin 19; PPV, positive predictive value; NPV, negative predictive value. |
||||||
|
Saleh et al. Diagnostic Pathology 2010 5:9 doi:10.1186/1746-1596-5-9 |
||||||